Publication Information

{'id': 'https://openalex.org/W2393261780', 'doi': None, 'title': 'Pharmacoeconomical analysis of gatifloxacin and levofloxacin in treatment of urinary tract infection', 'display_name': 'Pharmacoeconomical analysis of gatifloxacin and levofloxacin in treatment of urinary tract infection', 'publication_year': 2008, 'publication_date': '2008-01-01', 'ids': {'openalex': 'https://openalex.org/W2393261780', 'mag': '2393261780'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZWYY200809008.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765049179', 'display_name': 'Chinese Journal of Modern Drug Application', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4327874103', 'host_organization_name': 'China Modern Medicine Application Editorial Department', 'host_organization_lineage': ['https://openalex.org/P4327874103'], 'host_organization_lineage_names': ['China Modern Medicine Application Editorial Department'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5060452837', 'display_name': 'LU Mia', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'LU Mia', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5060452837'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 63}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11232', 'display_name': 'Urinary Tract Infections Management', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11232', 'display_name': 'Urinary Tract Infections Management', 'score': 0.9991, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10279', 'display_name': 'Urinary Bladder and Prostate Research', 'score': 0.9743, 'subfield': {'id': 'https://openalex.org/subfields/2748', 'display_name': 'Urology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11174', 'display_name': 'Pediatric Urology and Nephrology Studies', 'score': 0.9648, 'subfield': {'id': 'https://openalex.org/subfields/2735', 'display_name': 'Pediatrics, Perinatology and Child Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/gatifloxacin', 'display_name': 'Gatifloxacin', 'score': 0.9944125}], 'concepts': [{'id': 'https://openalex.org/C2777653605', 'wikidata': 'https://www.wikidata.org/wiki/Q2365016', 'display_name': 'Gatifloxacin', 'level': 4, 'score': 0.9944125}, {'id': 'https://openalex.org/C2781276175', 'wikidata': 'https://www.wikidata.org/wiki/Q424193', 'display_name': 'Levofloxacin', 'level': 3, 'score': 0.9771036}, {'id': 'https://openalex.org/C77411442', 'wikidata': 'https://www.wikidata.org/wiki/Q181100', 'display_name': 'Urinary system', 'level': 2, 'score': 0.70347583}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.63515794}, {'id': 'https://openalex.org/C3018023364', 'wikidata': 'https://www.wikidata.org/wiki/Q425265', 'display_name': 'Significant difference', 'level': 2, 'score': 0.5500553}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.46415907}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.15066954}, {'id': 'https://openalex.org/C501593827', 'wikidata': 'https://www.wikidata.org/wiki/Q12187', 'display_name': 'Antibiotics', 'level': 2, 'score': 0.0871076}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZWYY200809008.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2765049179', 'display_name': 'Chinese Journal of Modern Drug Application', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4327874103', 'host_organization_name': 'China Modern Medicine Application Editorial Department', 'host_organization_lineage': ['https://openalex.org/P4327874103'], 'host_organization_lineage_names': ['China Modern Medicine Application Editorial Department'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.78, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2391895943', 'https://openalex.org/W2391443606', 'https://openalex.org/W2389679608', 'https://openalex.org/W2384276669', 'https://openalex.org/W2380192441', 'https://openalex.org/W2379549916', 'https://openalex.org/W2379301747', 'https://openalex.org/W2376566812', 'https://openalex.org/W2375172359', 'https://openalex.org/W2371078797', 'https://openalex.org/W2367122755', 'https://openalex.org/W2367061970', 'https://openalex.org/W2365523912', 'https://openalex.org/W2364890258', 'https://openalex.org/W2362606943', 'https://openalex.org/W2361929353', 'https://openalex.org/W2361360488', 'https://openalex.org/W2355901589', 'https://openalex.org/W2350892219', 'https://openalex.org/W2349329768'], 'abstract_inverted_index': {'Objective': [0], 'To': [1], 'analyze': [2], 'the': [3, 110], 'cost-effect': [4, 34, 89, 105], 'of': [5, 11, 62, 67, 75, 112], 'gatifloxacin': [6, 31, 80, 98, 108], 'and': [7, 32, 40, 69, 71, 77, 82, 94, 100], 'levofloxacin': [8, 83, 101], 'in': [9, 35, 53, 79, 88, 97, 109], 'treatment': [10, 111], 'urinary': [12, 18, 113], 'tract': [13, 114], 'infection.Methods': [14], '80': [15], 'cases': [16], 'with': [17, 30, 42], 'infection': [19], 'were': [20, 28], 'randomly': [21], 'divided': [22], 'into': [23], '2': [24], 'groups,in': [25], 'which': [26], 'they': [27], 'treated': [29], 'levofloxacin,respectively.The': [33], 'two': [36, 57, 92], 'groups': [37], 'was': [38, 49, 85], 'analyzed': [39], 'compared': [41], 'each': [43], 'other': [44], 'by': [45], 'pharmacoeconomical': [46], 'method.Results': [47], 'There': [48], 'no': [50], 'significant': [51, 86], 'difference': [52, 87], 'therapeutic': [54], 'effect': [55], 'between': [56, 91], 'groups(P0.05),such': [58], 'as': [59], 'effective': [60], 'rate': [61], '92.5%': [63], 'and95.0%,bacterial': [64], 'clearance': [65], 'rates': [66, 74], '92.6%': [68], '85.7%': [70], 'undesired': [72], 'event': [73], '3.61%': [76], '4.22%': [78], 'group': [81, 99], 'group.However,there': [84], 'ratio': [90], 'group,83.0': [93], '45.5': [95], 'respectively': [96], 'group(P0.05).Conclusion': [102], 'Levofloxacin': [103], 'has': [104], 'advantage': [106], 'over': [107], 'infection.': [115]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2393261780', 'counts_by_year': [], 'updated_date': '2024-12-08T07:17:16.883146', 'created_date': '2016-06-24'}